- Benchmark ASINB0F7HY74K5
- MarketplaceCA
- Category ID6371098011
- Analyzed Products
- Keywordbody scrub
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-24
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入：它已经是低利润、强同质化、接近价格战的市场，而且新品牌样本为0，说明根本没有可验证的新进入机会。 现有唯一可见的强势玩家是老品牌 BIO SPECTRA ATTITUDE，但它的两款样本产品都不赚钱，连高销量也只能换来很薄的利润；这对大品牌和小商家都不是好信号。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
Old Brands
#Budget Requirement
Listing这不是一个适合进入的市场：利润率太低，而且价格战已经非常明显。 你当前预算50万CNY表面上足够做单个ASIN的前期铺货与推广，但按这个赛道的真实表现来看，核心样本ASIN B0F7HY74K5 只有4.8%利润率、月销600、月营收7,458 CNY，却仍然被判定为非盈利；同品牌另一个ASIN B0F7M39ZZV 也同样非盈利。这个市场对大多数卖家来说不是“能不能做”，而是“做了也很难赚到钱”。
证据非常直接：市场整体盈利率是0%，新上架产品的盈利率也是0%，说明不是个别产品失利，而是整个赛道都在低利润区间。 B0F7HY74K5 早期投入约4,325.64 CNY，其中广告就占971.54 CNY，说明想要跑量必须持续烧推广；但它最后仍只有4.8%利润率，远低于你应当接受的15%及以上健康线。产品外观看起来也没有明显差异化，黑色极简男士除臭棒、75克标准棒状、天然无铝/EWG这些卖点都很常见，属于高度同质化。对小商家而言，这里没有可复制的“真实成功小店案例”可作为标杆；对大品牌而言，BIO SPECTRA ATTITUDE 这种旧品牌虽然有600单/月的销售体量，但依然没能跑出盈利，说明即使有品牌力也很难摆脱低毛利。
Early sourcing + logistics + marketing budget (CAD)N/AExplains the budgetWith all these investments, who has profitable new releases
Alternatives- 可替代为药店/超市的基础款除臭剂：通常更便宜、更容易买到，且日常止汗除味的使用门槛更低；如果用户只是想解决体味问题，这类产品是最直接的降级替代。
- 可替代为无香型或敏感肌型基础除臭产品：相比强调天然、有机、EWG认证的产品，配方更简单、价格常更低，适合想减少成分顾虑但不追求“高端天然叙事”的用户。
- 可替代为除臭湿巾/身体清洁湿巾：在外出、健身、通勤场景下更灵活，不需要完整换产品体系，属于更容易临时补救体味的低成本方案。
- 可替代为足部/腋下局部控味喷雾或粉末：这类单点解决方案通常比高端身体护理产品更便宜，且针对异味来源更直接，适合预算敏感型用户。
- 可替代为基础沐浴露 + 更频繁清洁的组合：虽然不是同类升级替代，但对只想控制日常异味的人来说，这种方案采购更方便、成本更低，也避免购买专门的身体磨砂/护理产品。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入：整体利润率几乎被压到地板上，且新品牌没有任何可验证的盈利样本，说明这里已经是低利润、强竞争、偏价格战的市场。对大品牌和小商家都不是好机会；如果要硬进，基本只能靠更重的投放和更强的品牌资源，普通卖家不适合下场。
证据很直接：当前核心样本里，BIO SPECTRA ATTITUDE 的 ASIN B0F7HY74K5 月销约 600件、月营收约 C$7,458，但利润率只有 4.8%，低于可接受门槛，属于高销量但不赚钱的典型；该 ASIN 进入市场的早期投入约 C$4,325.64，其中广告约 C$971.54，说明要拿到这点销量并不便宜。品牌层面，BIO SPECTRA ATTITUDE 只有 2个样本产品，盈利产品数 0，可识别盈利率 0%，这是一个明确的失败信号，不是适合小商家抄作业的案例。市场利润分布也印证这一点：样本中只有 1个产品 落在 0%~10% 利润区间，没有任何 ≥10% 的有效盈利样本；新产品利润分布为 0，说明新进入者几乎没有跑出来的空间。
对两种进入者都要给出结论：大品牌也不应把这里当成可轻松扩张的市场，因为现在能活下来的样本更像是老品牌靠资源撑量，而不是靠高利润扩张；能参考的只有 BIO SPECTRA ATTITUDE 这种“高销量、低利润、重广告”的老品牌打法，但这不是小商家能复制的路径。小商家更不该进，因为目前没有看到真实的“小而美成功案例”，也没有任何可验证的 <300 评的新品牌成功样本；相反，现有样本已接近价格战区间，若要硬做，大概率需要持续加投、压价和长期亏损换排名。我的建议很明确：不要进入。
Old brand with the most profitable new productsBIO SPECTRA ATTITUDE
Recent Monthly Revenue (CAD):-(-)B0F7M39ZZVBrand is an old entry in this marketOld ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 100 MOQRecent Monthly Revenue (CAD):C$7,458.00(600pcs/month)B0F7HY74K5 (3.7/5 (456 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseNet profit margin below 10.00%#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0F7HY74K5 (3.7/5 (456 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseNet profit margin below 10.00%Sales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0F7M39ZZVBrand is an old entry in this marketOld ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入。当前样本里可识别利润的产品中，盈利率是0%，新上架产品盈利率也是0%；再看利润分布，已知利润样本里50%落在0%~10%低利润区间，另外50%甚至无法形成有效利润，说明这不是健康竞争，而是低毛利、强挤压的市场。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Non-Profitable Products
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
B0F7HY74K5BIO SPECTRA ATTITUDE2025-05-05NoC$12.43600pcsC$7458.04.81%C$358.73B0F7M39ZZVBIO SPECTRA ATTITUDE2025-05-06NoC$--pcsC$--%C$-No profitable product data available for new products#New Product Success Rates
Listing这个市场不值得进入，结论很明确：已被老品牌主导，而且没有真正可复制的新品牌成功样本。 当前样本里只有 1 个老品牌 BIO SPECTRA ATTITUDE，0 个新品牌，0 个新发布产品；整体可识别为盈利的产品比例是 0%，新发布产品盈利率也是 0%。这不是一个给新手留空间的市场，而是一个由成熟品牌占位、利润被压到很低的市场。
No data availableNo data availableNo data available#Success Rate by Entry Time
Listing结论很明确：这个市场不值得进入，属于低利润、弱差异化、已接近价格战的高风险市场。 现有数据里，市场整体可识别的盈利率是0.00%，新进入产品的盈利率也是0.00%；再加上只有1个品牌、且这个老品牌 BIO SPECTRA ATTITUDE 自己的两款产品全部不盈利，说明不是“新手有机会”，而是“连存量玩家都难赚钱”。
证据也很直接：B0F7HY74K5（BIO SPECTRA ATTITUDE）月销600件、月营收约C$7,458，但利润率只有4.81%，远低于可接受的15%门槛；另一款 B0F7M39ZZV 直接不活跃。 失败原因不是偶然，而是“低利润+高度同质化+竞争过强”；产品卖点集中在 EWG、95%天然、无铝这类常见标签，包装和规格也没有明显差异化。市场节奏上，时间趋势没有显示出有效的新进入增长，盈利时间表几乎全是空的，说明最近没有形成可复制的成功路径。按你的规则，这已经是价格战风险区，不是适合大品牌或小商家切入的市场。
对两类卖家都不友好：大品牌没有可抄的稳定盈利模板，小商家更没有真实的成功样本。 当前没有新品牌案例，也没有<300评论的真正小商家成功案例；相反，现成可见的强势样本是老品牌，且其单品要靠600件/月销量才能勉强维持很低利润。你如果硬要做，至少要准备对标这种级别的投放和渠道能力，但这仍然不保证盈利。短结论：不要进入。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 0 2026 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases